泰格医药

- 300347

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
泰格医药(300347) 利润表
单位:万元
报表日期2022-09-302022-06-302022-03-312021-12-312021-09-30
一、营业总收入540,601.88359,420.92181,785.90521,353.81339,501.52
营业收入540,601.88359,420.92181,785.90521,353.81339,501.52
二、营业总成本387,254.64259,701.13133,963.48363,776.48228,670.80
营业成本323,744.54216,733.33111,201.14294,288.30180,729.19
营业税金及附加1,382.17854.75349.982,253.691,570.21
销售费用10,793.798,003.973,851.3612,939.929,584.97
管理费用46,119.8031,365.0915,894.6754,748.0338,864.88
财务费用-11,891.20-8,308.03-3,032.45-21,636.31-17,559.02
研发费用17,105.5411,052.015,698.7821,182.8615,480.57
资产减值损失----------
公允价值变动收益40,258.7841,327.6412,513.11181,538.97111,734.37
投资收益9,246.618,644.565,555.3331,228.2912,517.35
其中:对联营企业和合营企业的投资收益--3,555.59--1,434.82--
汇兑收益----------
三、营业利润200,100.72148,092.0365,438.13369,696.69234,084.18
加:营业外收入1,103.25407.98173.29632.65243.30
减:营业外支出603.86513.4811.191,872.76737.15
其中:非流动资产处置损失----------
四、利润总额200,600.11147,986.5265,600.23368,456.58233,590.34
减:所得税费用23,376.6716,223.928,203.1829,286.3615,018.22
五、净利润177,223.44131,762.6057,397.05339,170.22218,572.11
归属于母公司所有者的净利润160,465.88119,200.4051,841.68287,416.30178,105.01
少数股东损益16,757.5712,562.205,555.3751,753.9240,467.10
六、每股收益
基本每股收益(元/股)1.86001.38000.60003.31002.0500
稀释每股收益(元/股)1.86001.38000.60003.30002.0400
七、其他综合收益35,058.2318,483.39-252.26-8,991.81-3,319.94
八、综合收益总额212,281.67150,245.9957,144.79330,178.41215,252.17
归属于母公司所有者的综合收益总额186,962.01133,402.1451,787.12281,018.36175,927.47
归属于少数股东的综合收益总额25,319.6516,843.855,357.6749,160.0539,324.70
下载全部历史数据到excel中 返回页顶